Regional Differences in the Obesity Crisis

Video

Episode 3 of Crisis Point examines the regional differences in obesity, from issues with nutrition and food insecurity to the use of the phrase "food desert".

Episode Highlights

0:00 - Introduction

0:23 - Differences in Obesity Crisis

4:48 - Regions in US and beyond

7:08 - Food Insecurity

10:10 - Nutritional Ability

15:46 - Public Health

17:24 - Conclusion

This is HCPLive® Crisis Point, a comprehensive look at the public health crises affecting the United States today, with global implications tomorrow.

So far, we have examined the scope of the obesity crisis and the clinical aspects and burdens that make up both the treatment and complications of care in patients with obesity.

Our episode today once more widens the idea of a public health crisis outside of the clinical burdens back into the public health space, with the thematic element of the regional differences in obesity rates in both the United States and beyond.

Topics discussed in the episode include issues in nutritional options, particular regional burdens, the connection between the United States and third-world countries, food insecurity and poverty, as well as the use of the phrase "food desert".

Again, we feature our cast of experts including:

  • Hans Schmidt, MD, Division Chief, Bariatric Surgery, Hackensack University Medical Center
  • Shauna Downs, PhD, Assistant Professor, Rutgers School of Public Health
  • Jun Tashiro, MD, Pediatric Surgeon, Hassenfeld Children’s Hospital, NYU Langone Health
  • Jose Aleman, MD, Assistant Professor, NYU Langone Health
  • Louis Aronne, MD, Chief Medical Officer of Intellihealth and Medical Director, Comprehensive Weight Control Center, Weill Cornell Medical Center

Thanks for watching. Stay tuned for next week's final episode on the blueprint to ending the crisis.

Want to catch up? Check out Episode 1 and Episode 2 of HCPLive® Crisis Point - Obesity Crisis.

Related Videos
Laxmi Mehta, MD | Credit: American Heart Association
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
Guillaume Lassailly: How Do We Value Bariatric Surgery in 2023?
Guillaume Lassailly: The Role of MASH, Fibrosis in Bariatric Surgery Survival
Taha Qazi, MD: Evolving Bariatric Surgery Value in GI
© 2024 MJH Life Sciences

All rights reserved.